Global Immunotherapeutic Drugs Market Growth (Status and Outlook) 2024-2030

2024

Global Immunotherapeutic Drugs Market Growth (Status and Outlook) 2024-2030

Name: Global Immunotherapeutic Drugs Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001399
Price: 3450 USD
Availability: InStock
Rating: 4 (8.45 reviews)

Immunotherapeutic Drugs market size was valued at US$ 173.30 billion in 2023, reflecting growing demand for advanced therapies in oncology, autoimmune diseases, and infections.

Bonafide Trust
20-09-2024
Pages : 104
Figures : 79
Tables : 102
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global immunotherapeutic drugs market is a rapidly growing segment of the pharmaceutical industry, valued at approximately USD 110.55 billion in 2021 and projected to expand at a compound annual growth rate (CAGR) of around 6.92% from 2022 to 2030. Immunotherapy involves using the body's immune system to fight diseases, including cancer, autoimmune disorders, and infectious diseases. The market is driven by the rising incidence of chronic diseases, advancements in biotechnology, and a growing understanding of the immune system's role in combating illnesses. Key players in the industry are focusing on developing innovative therapies, such as monoclonal antibodies, immunomodulators, and cell therapies, to improve patient outcomes. The emergence of combination therapies and personalized medicine is also contributing to market growth. Despite the high costs associated with immunotherapy treatments, the market is expected to continue its upward trajectory due to the increasing demand for effective and targeted treatments.

According to Publisher, the global Immunotherapeutic Drugs market size was valued at US$ 173300 million in 2023. With growing demand in downstream market, the Immunotherapeutic Drugs is forecast to a readjusted size of US$ 376280 million by 2030 with a CAGR of 11.7% during review period. The global immunotherapeutic drugs market is driven by several key factors, including the rising prevalence of chronic diseases, advancements in biotechnology, and increasing investments in research and development. Chronic diseases such as cancer, autoimmune disorders, and infectious diseases are on the rise, creating a significant demand for effective treatments. Immunotherapeutic drugs, which harness the body's immune system to fight diseases, offer a promising alternative to traditional treatments like chemotherapy. The continuous advancements in biotechnology, including the development of monoclonal antibodies, checkpoint inhibitors, and cell therapies, are enhancing the efficacy and safety of immunotherapies. Additionally, increasing investments in research and development by pharmaceutical companies and government agencies are accelerating the discovery and commercialization of new immunotherapeutic drugs. The growing awareness and acceptance of immunotherapy among healthcare professionals and patients are also contributing to market growth. Despite the high costs associated with immunotherapy treatments, the potential for improved patient outcomes and the development of combination therapies are expected to drive the market forward. The research report highlights the growth potential of the global Immunotherapeutic Drugs market. Immunotherapeutic Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immunotherapeutic Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immunotherapeutic Drugs market.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global immunotherapeutic drugs market is segmented by type into monoclonal antibodies, vaccines, checkpoint inhibitors, interferons, interleukins, and other drugs. Monoclonal antibodies are designed to target specific antigens on cancer cells, making them highly effective in treating various types of cancer. Vaccines in immunotherapy are used to stimulate the immune system to recognize and attack cancer cells. Checkpoint inhibitors work by blocking proteins that prevent the immune system from attacking cancer cells, thereby enhancing the body's natural defenses. Interferons are proteins that have antiviral, antitumor, and immunomodulatory effects, used in the treatment of diseases like hepatitis and certain cancers. Interleukins are a group of cytokines that play a crucial role in the immune response, used in therapies for conditions such as leukemia and lymphoma. The "other drugs" category includes various novel immunotherapeutic agents that are being developed to target different diseases. Each type of immunotherapeutic drug has its own unique mechanism of action and application, contributing to the overall growth and diversity of the market. Continuous research and development, along with strategic collaborations between pharmaceutical companies and research institutions, are driving innovation and expanding the range of available immunotherapeutic drugs.

The global immunotherapeutic drugs market is segmented by application into hospitals, clinics, and other healthcare facilities. Hospitals are the primary users of immunotherapeutic drugs, given their extensive infrastructure and capacity to handle complex treatments and large patient volumes. Clinics, including specialized cancer treatment centers and outpatient facilities, also play a crucial role in administering immunotherapies, offering more personalized and accessible care. The "other" category encompasses various healthcare settings, such as research institutions and laboratories, where immunotherapeutic drugs are used for clinical trials and experimental treatments. Each application segment caters to specific patient needs and treatment protocols, driving the demand for diverse and effective immunotherapeutic drugs. The continuous advancements in medical technology, increasing prevalence of chronic diseases, and growing awareness of immunotherapy benefits are propelling the market forward. Additionally, strategic collaborations between pharmaceutical companies and healthcare providers are enhancing the availability and accessibility of immunotherapeutic treatments, ensuring comprehensive and innovative care for patients.

The regional analysis of the global immunotherapeutic drugs market reveals distinct trends and growth patterns across different geographical areas, highlighting its critical role in supporting regional economic development. The North American region dominates the market, driven by a high prevalence of chronic diseases, advanced healthcare infrastructure, and significant investments in research and development. The United States and Canada are key players, with numerous immunotherapeutic drugs approved for various indications, including cancer and autoimmune disorders. The European region also holds a substantial market share, supported by stringent regulatory approvals and a growing focus on personalized medicine. Countries like Germany, France, and the United Kingdom are leading the way in immunotherapy research and development. The Asia-Pacific region is experiencing rapid growth, fueled by increasing healthcare expenditure, rising awareness of immunotherapy benefits, and a growing patient population. China and Japan are notable markets, with a focus on developing innovative immunotherapeutic drugs and expanding clinical trials. The Latin American region and the Middle East and Africa regions are emerging markets, with increasing investments in healthcare infrastructure and a rising demand for advanced treatments. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global immunotherapeutic drugs market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immunotherapeutic Drugs Market Size 2019-2030
2.1.2 Immunotherapeutic Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immunotherapeutic Drugs Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Vaccines
2.2.3 Checkpoint Inhibitor
2.2.4 Interferon
2.3 Immunotherapeutic Drugs Market Size by Type
2.3.1 Immunotherapeutic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
2.4 Immunotherapeutic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Immunotherapeutic Drugs Market Size by Application
2.5.1 Immunotherapeutic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
3 Immunotherapeutic Drugs Market Size by Player
3.1 Immunotherapeutic Drugs Market Size Market Share by Players
3.1.1 Global Immunotherapeutic Drugs Revenue by Players (2019-2024)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapeutic Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immunotherapeutic Drugs by Regions
4.1 Immunotherapeutic Drugs Market Size by Regions (2019-2024)
4.2 Americas Immunotherapeutic Drugs Market Size Growth (2019-2024)
4.3 APAC Immunotherapeutic Drugs Market Size Growth (2019-2024)
4.4 Europe Immunotherapeutic Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Immunotherapeutic Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Immunotherapeutic Drugs Market Size by Country (2019-2024)
5.2 Americas Immunotherapeutic Drugs Market Size by Type (2019-2024)
5.3 Americas Immunotherapeutic Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunotherapeutic Drugs Market Size by Region (2019-2024)
6.2 APAC Immunotherapeutic Drugs Market Size by Type (2019-2024)
6.3 APAC Immunotherapeutic Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immunotherapeutic Drugs by Country (2019-2024)
7.2 Europe Immunotherapeutic Drugs Market Size by Type (2019-2024)
7.3 Europe Immunotherapeutic Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immunotherapeutic Drugs by Region (2019-2024)
8.2 Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Immunotherapeutic Drugs Market Forecast
10.1 Global Immunotherapeutic Drugs Forecast by Regions (2025-2030)
10.1.1 Global Immunotherapeutic Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Immunotherapeutic Drugs Forecast
10.1.3 APAC Immunotherapeutic Drugs Forecast
10.1.4 Europe Immunotherapeutic Drugs Forecast
10.1.5 Middle East & Africa Immunotherapeutic Drugs Forecast
10.2 Americas Immunotherapeutic Drugs Forecast by Country (2025-2030)
10.2.1 United States Immunotherapeutic Drugs Market Forecast
10.2.2 Canada Immunotherapeutic Drugs Market Forecast
10.2.3 Mexico Immunotherapeutic Drugs Market Forecast
10.2.4 Brazil Immunotherapeutic Drugs Market Forecast
10.3 APAC Immunotherapeutic Drugs Forecast by Region (2025-2030)
10.3.1 China Immunotherapeutic Drugs Market Forecast
10.3.2 Japan Immunotherapeutic Drugs Market Forecast
10.3.3 Korea Immunotherapeutic Drugs Market Forecast
10.3.4 Southeast Asia Immunotherapeutic Drugs Market Forecast
10.3.5 India Immunotherapeutic Drugs Market Forecast
10.3.6 Australia Immunotherapeutic Drugs Market Forecast
10.4 Europe Immunotherapeutic Drugs Forecast by Country (2025-2030)
10.4.1 Germany Immunotherapeutic Drugs Market Forecast
10.4.2 France Immunotherapeutic Drugs Market Forecast
10.4.3 UK Immunotherapeutic Drugs Market Forecast
10.4.4 Italy Immunotherapeutic Drugs Market Forecast
10.4.5 Russia Immunotherapeutic Drugs Market Forecast
10.5 Middle East & Africa Immunotherapeutic Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Immunotherapeutic Drugs Market Forecast
10.5.2 South Africa Immunotherapeutic Drugs Market Forecast
10.5.3 Israel Immunotherapeutic Drugs Market Forecast
10.5.4 Turkey Immunotherapeutic Drugs Market Forecast
10.5.5 GCC Countries Immunotherapeutic Drugs Market Forecast
10.6 Global Immunotherapeutic Drugs Forecast by Type (2025-2030)
10.7 Global Immunotherapeutic Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Immunotherapeutic Drugs Product Offered
11.1.3 Roche Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Immunotherapeutic Drugs Product Offered
11.2.3 Merck Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Immunotherapeutic Drugs Product Offered
11.3.3 Novartis Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Immunotherapeutic Drugs Product Offered
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Immunotherapeutic Drugs Product Offered
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Immunotherapeutic Drugs Product Offered
11.6.3 AbbVie Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 ELI Lilly
11.7.1 ELI Lilly Company Information
11.7.2 ELI Lilly Immunotherapeutic Drugs Product Offered
11.7.3 ELI Lilly Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ELI Lilly Main Business Overview
11.7.5 ELI Lilly Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Immunotherapeutic Drugs Product Offered
11.8.3 Amgen Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Immunotherapeutic Drugs Product Offered
11.9.3 AstraZeneca Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Information
11.10.2 Bristol-Mysers Squibb Immunotherapeutic Drugs Product Offered
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bristol-Mysers Squibb Main Business Overview
11.10.5 Bristol-Mysers Squibb Latest Developments
12 Research Findings and Conclusion

Table 1. Immunotherapeutic Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Monoclonal Antibody
Table 3. Major Players of Vaccines
Table 4. Major Players of Checkpoint Inhibitor
Table 5. Major Players of Interferon
Table 6. Immunotherapeutic Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Immunotherapeutic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Table 9. Immunotherapeutic Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Immunotherapeutic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Table 12. Global Immunotherapeutic Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Immunotherapeutic Drugs Revenue Market Share by Player (2019-2024)
Table 14. Immunotherapeutic Drugs Key Players Head office and Products Offered
Table 15. Immunotherapeutic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immunotherapeutic Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Immunotherapeutic Drugs Market Size Market Share by Regions (2019-2024)
Table 20. Global Immunotherapeutic Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Immunotherapeutic Drugs Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Immunotherapeutic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Immunotherapeutic Drugs Market Size Market Share by Country (2019-2024)
Table 24. Americas Immunotherapeutic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Table 26. Americas Immunotherapeutic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Table 28. APAC Immunotherapeutic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Immunotherapeutic Drugs Market Size Market Share by Region (2019-2024)
Table 30. APAC Immunotherapeutic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Table 32. APAC Immunotherapeutic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Table 34. Europe Immunotherapeutic Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Immunotherapeutic Drugs Market Size Market Share by Country (2019-2024)
Table 36. Europe Immunotherapeutic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Table 38. Europe Immunotherapeutic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Immunotherapeutic Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Immunotherapeutic Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Immunotherapeutic Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Immunotherapeutic Drugs
Table 47. Key Market Challenges & Risks of Immunotherapeutic Drugs
Table 48. Key Industry Trends of Immunotherapeutic Drugs
Table 49. Global Immunotherapeutic Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Immunotherapeutic Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Immunotherapeutic Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Roche Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 54. Roche Immunotherapeutic Drugs Product Offered
Table 55. Roche Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Merck Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 59. Merck Immunotherapeutic Drugs Product Offered
Table 60. Merck Main Business
Table 61. Merck Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Merck Latest Developments
Table 63. Novartis Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 64. Novartis Immunotherapeutic Drugs Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Latest Developments
Table 68. Johnson & Johnson Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 69. Johnson & Johnson Immunotherapeutic Drugs Product Offered
Table 70. Johnson & Johnson Main Business
Table 71. Johnson & Johnson Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Johnson & Johnson Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 74. GlaxoSmithKline Immunotherapeutic Drugs Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlaxoSmithKline Latest Developments
Table 78. AbbVie Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 79. AbbVie Immunotherapeutic Drugs Product Offered
Table 80. AbbVie Main Business
Table 81. AbbVie Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. AbbVie Latest Developments
Table 83. ELI Lilly Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 84. ELI Lilly Immunotherapeutic Drugs Product Offered
Table 85. ELI Lilly Main Business
Table 86. ELI Lilly Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. ELI Lilly Latest Developments
Table 88. Amgen Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 89. Amgen Immunotherapeutic Drugs Product Offered
Table 90. Amgen Main Business
Table 91. Amgen Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Amgen Latest Developments
Table 93. AstraZeneca Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 94. AstraZeneca Immunotherapeutic Drugs Product Offered
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. AstraZeneca Latest Developments
Table 98. Bristol-Mysers Squibb Details, Company Type, Immunotherapeutic Drugs Area Served and Its Competitors
Table 99. Bristol-Mysers Squibb Immunotherapeutic Drugs Product Offered
Table 100. Bristol-Mysers Squibb Main Business
Table 101. Bristol-Mysers Squibb Immunotherapeutic Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bristol-Mysers Squibb Latest Developments

Figure 1. Immunotherapeutic Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunotherapeutic Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immunotherapeutic Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immunotherapeutic Drugs Sales Market Share by Country/Region (2023)
Figure 8. Immunotherapeutic Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immunotherapeutic Drugs Market Size Market Share by Type in 2023
Figure 10. Immunotherapeutic Drugs in Hospitals
Figure 11. Global Immunotherapeutic Drugs Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immunotherapeutic Drugs in Clinics
Figure 13. Global Immunotherapeutic Drugs Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Immunotherapeutic Drugs in Other
Figure 15. Global Immunotherapeutic Drugs Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Immunotherapeutic Drugs Market Size Market Share by Application in 2023
Figure 17. Global Immunotherapeutic Drugs Revenue Market Share by Player in 2023
Figure 18. Global Immunotherapeutic Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immunotherapeutic Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immunotherapeutic Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immunotherapeutic Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immunotherapeutic Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immunotherapeutic Drugs Value Market Share by Country in 2023
Figure 24. United States Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immunotherapeutic Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Immunotherapeutic Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Immunotherapeutic Drugs Market Size Market Share by Application in 2023
Figure 31. China Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immunotherapeutic Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immunotherapeutic Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immunotherapeutic Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immunotherapeutic Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immunotherapeutic Drugs Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted